ArticleFrontiers in immunology2026

Case Report: Rapid recurrence of psoriasiform dermatitis upon sequential anti-PD-1 therapy with pembrolizumab and tislelizumab with 3-year follow-up.

Chao-Cheng Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.